Managers’ transactions

May 25,2023 

Announcement no. 32 

  

Managers’ transactions  

Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in Pharma Equity Group A/S made by persons discharging managerial responsibilities in Pharma Equity Group and/or persons closely related with them.   

  

    1. Details of the person discharging managerial responsibilities/person closely associated  
a) Name      Thomas Kaas Selsø 
2. Reason for the notification  
 a) Position/status    CEO 
   b) Initial notification/amendment      Initial notification  
  3. Details of the issuer  
   a) Name     Pharma Equity Group A/S  
    b) LEI     2138008SUI4D917FKN20   
 c) Trade name     PEG 
   4. Details of the transaction(s)  
   a) Description of the financial instrument, type    of instrument and Identification code     Shares, ISIN code DK0061155009 
   b) Nature of the transaction     Purchase  
   c) Price(s) and volume(s)   Price: DKK 167,225Volume: 551,724  
    d) Aggregated information  - Aggregated volume  - Aggregated price     N/A  
   e) Date of the transaction      25-05-2023, 09:26 CEST 
  f) Place of the transaction     Nasdaq Copenhagen A/S 

For further information, please contact:  

  

Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14 

Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00. 

Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Pharma Equity Group A/s.
Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Pharma Equity Group A/s.